444 related articles for article (PubMed ID: 23391119)
1. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
Strosberg JR
Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
[TBL] [Abstract][Full Text] [Related]
2. Primary malignant tumors of the adrenal glands.
Almeida MQ; Bezerra-Neto JE; Mendonça BB; Latronico AC; Fragoso MCBV
Clinics (Sao Paulo); 2018 Dec; 73(suppl 1):e756s. PubMed ID: 30540124
[TBL] [Abstract][Full Text] [Related]
3. Genetics of adrenal tumors.
Opocher G; Schiavi F; Cicala MV; Patalano A; Mariniello B; Boaretto F; Zovato S; Pignataro V; Macino B; Negro I; Mantero F
Minerva Endocrinol; 2009 Jun; 34(2):107-21. PubMed ID: 19471236
[TBL] [Abstract][Full Text] [Related]
4. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
Santarpia L; Habra MA; Jiménez C
Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
[TBL] [Abstract][Full Text] [Related]
5. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
Moraitis AG; Martucci VL; Pacak K
Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytomas and Paragangliomas: An Update on Recent Molecular Genetic Advances and Criteria for Malignancy.
Guo Z; Lloyd RV
Adv Anat Pathol; 2015 Sep; 22(5):283-93. PubMed ID: 26262510
[TBL] [Abstract][Full Text] [Related]
7. Genetics of pheochromocytomas and paragangliomas.
Opocher G; Schiavi F
Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
[TBL] [Abstract][Full Text] [Related]
8. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
9. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
Bertherat J; Gimenez-Roqueplo AP
Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
[TBL] [Abstract][Full Text] [Related]
10. PRECISION MEDICINE IN ADRENAL DISORDERS: THE NEXT GENERATION.
Ghayee HK; Vinik AI; Pacak K;
Endocr Pract; 2017 Jun; 23(6):672-679. PubMed ID: 28332880
[TBL] [Abstract][Full Text] [Related]
11. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
[TBL] [Abstract][Full Text] [Related]
12. Familial predisposition to adrenocortical tumors: clinical and biological features and management strategies.
Ribeiro RC; Pinto EM; Zambetti GP
Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):477-90. PubMed ID: 20833338
[TBL] [Abstract][Full Text] [Related]
13. Pheochromocytoma: a review.
Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
[TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma and paraganglioma: recent progress and new vistas for improved patient care.
Eisenhofer G; Schott M; Bornstein S
Horm Metab Res; 2012 May; 44(5):325-7. PubMed ID: 22566193
[No Abstract] [Full Text] [Related]
15. Genomic Landscape of Pheochromocytoma and Paraganglioma.
Jochmanova I; Pacak K
Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
[TBL] [Abstract][Full Text] [Related]
16. Endocrine tumors as part of inherited tumor syndromes.
Zhang Y; Nosé V
Adv Anat Pathol; 2011 May; 18(3):206-18. PubMed ID: 21490438
[TBL] [Abstract][Full Text] [Related]
17. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
[TBL] [Abstract][Full Text] [Related]
18. [Malignant tumors of the adrenal: contribution to the repository CCAFU INCa].
Sèbe P; Rigaud J; Avancès C; Brunaud L; Caillard C; Camparo P; Carnaille B; Culine S; Durand X; Mathonnet M; Mirallie E; Soulié M;
Prog Urol; 2010 Nov; 20 Suppl 4():S310-6. PubMed ID: 21129649
[No Abstract] [Full Text] [Related]
19. Molecular basis of adrenocortical carcinomas.
Soon PS; Sidhu SB
Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
[TBL] [Abstract][Full Text] [Related]
20. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
